- Home
- MIRA vs AMS Comparison
MIRA vs AMS Comparison
Compare MIRA & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- AMS
- Stock Information
- Founded
- MIRA 2020
- AMS 1980
- Country
- MIRA United States
- AMS United States
- Employees
- MIRA N/A
- AMS N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- MIRA Health Care
- AMS Health Care
- Exchange
- MIRA Nasdaq
- AMS Nasdaq
- Market Cap
- MIRA 26.1M
- AMS 17.2M
- IPO Year
- MIRA 2023
- AMS N/A
- Fundamental
- Price
- MIRA $1.39
- AMS $2.51
- Analyst Decision
- MIRA Strong Buy
- AMS
- Analyst Count
- MIRA 1
- AMS 0
- Target Price
- MIRA $17.00
- AMS N/A
- AVG Volume (30 Days)
- MIRA 196.3K
- AMS 3.8K
- Earning Date
- MIRA 08-14-2025
- AMS 08-13-2025
- Dividend Yield
- MIRA N/A
- AMS N/A
- EPS Growth
- MIRA N/A
- AMS N/A
- EPS
- MIRA N/A
- AMS N/A
- Revenue
- MIRA N/A
- AMS $29,251,000.00
- Revenue This Year
- MIRA N/A
- AMS $5.06
- Revenue Next Year
- MIRA N/A
- AMS N/A
- P/E Ratio
- MIRA N/A
- AMS N/A
- Revenue Growth
- MIRA N/A
- AMS 26.61
- 52 Week Low
- MIRA $0.73
- AMS $2.27
- 52 Week High
- MIRA $2.56
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- MIRA 45.09
- AMS 47.74
- Support Level
- MIRA $1.35
- AMS $2.41
- Resistance Level
- MIRA $1.42
- AMS $2.55
- Average True Range (ATR)
- MIRA 0.06
- AMS 0.09
- MACD
- MIRA -0.01
- AMS -0.00
- Stochastic Oscillator
- MIRA 23.81
- AMS 23.58
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.